Tuesday, July 19, 2016
Merck, a leading science and technology company, is relaunching its global network of customer collaboration centers, providing customers a shared, exploratory environment with scientists and engineers working to solve their toughest biomanufacturing challenges, helping accelerate development of new therapies.
Formerly known as biomanufacturing science training centers, the new state-of-the art M Lab™ concept will include a simulated manufacturing environment that provides customers a setting that fosters education and full end-to-end development support. The centers are created especially for customer collaboration in which problem solving for processing issues take place. Customers participate in product demonstrations, hands-on training and experiments, as well as apply best practices and new approaches to develop, optimize and scale-up processes and simplify global technology transfer.
"We are the only company that offers full end-to-end process training, and we do it side-by-side with our customers, working together to solve critical challenges," said Udit Batra, Member of the Merck Executive Board and CEO, Life Science.
Now reimagined and reengineered as M Lab™ Collaboration Centers, Merck has taken its industry-leading concept to the next level by creating unique and inspiring settings where customers can explore new ways to increase productivity and improve processes in close collaboration Merck's team of experts.
"These centers have been an important resource for our customers and the biopharma industry for more than two decades and will continue to be important as we grow," Batra added.
Merck unveiled its first remodeled center in Tokyo, Japan on June 29, 2016. The network, established in 1995, will also include locations in Brazil, China, France, India, Singapore, South Korea and the United States. Formal relaunch of these centers will take place throughout the remainder of 2016 and 2017 with openings of the new M Lab™ concept in France, India, China, South Korea and the United States.
Each center will welcome customers, collaborators from government, academia, regulatory bodies and industry associations, offering application best practices and knowledge sharing tailored to address the specific needs of the local biomanufacturing industry. Customers will have access to sizing and simulation tools and methodologies as well as analytical and modeling support. Hands-on and classroom-style training sessions and education programs are also provided.
Click here to learn more about the M Lab™ Collaboration Centers and view videos of Merck's facilities.
All Merck news releases are distributed by email at the same time they become available on the Merck website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.
About Merck
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life - from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck generated sales of € 12.85 billion in 66 countries.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
